FindTrial
Sign In

Efficacy of Vestibular Stimulation Therapy on Sensory Processing and Functional Outcomes in Children with Spastic Cerebral Palsy

Prevalence of Sensory Processing Pattern Deficits using Child Sensory Profile–2 and Evaluating the Efficacy of Vestibular Stimulation Therapy in Improving Balance and Gross Motor Function in Children with Spastic Cerebral Palsy in Delhi NCR

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/10/037537
Enrollment
30
Registered
2021-10-25
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G80- Cerebral palsy

Interventions

Intervention1: Vestibular Stimulation Therapy: Will be using platform and bolster swings, then targeting activities and pushing and pulling activities, visual and proprioceptive guided activities will

Sponsors

Delhi Pharmaceutical Sciences and Research University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Children clinically diagnosed with spastic cerebral palsy with GMFCS level either I, II or III. • Children with Spastic Cerebral Palsy of either gender aged 3 to 12 years • Minimum 19 raw score on movement processing section of child sensory profile-2 • Ability to follow simple command.

Exclusion criteria

Exclusion criteria: • Children with neurochemical blocks or had orthopedic surgeries in the previous six months • Children with mental retardation or diagnosis within the Autism Spectrum Disorders. • Children with epileptic attack in past 6 months. • Children with athetoid, ataxic, flaccid cerebral palsy.

Design outcomes

Primary

MeasureTime frame
1. GMFM (Gross Motor Function Measure(GMFM-66) 2. PBS (Pediatric Balance Scale)Timepoint: Baseline then after 6 weeks.—

Secondary

MeasureTime frame
1. Child SP2 (Child Sensory Profile 2)- Movement processing section 2. GAS (Goal Attainment Scale)Timepoint: 1. Baseline 2. 6 weeks—

Countries

India

Contacts

Public ContactSAPNA DHIMAN

Delhi Pharmaceutical Sciences and Research University

goyalrk@gmail.com9825719111

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026